miteman Exelixis (NASDAQ:EXEL) announced late Friday that it filed a lawsuit against Cipla, alleging that the Indian drugmaker has violated…
Read More »miteman Exelixis (NASDAQ:EXEL) announced late Friday that it filed a lawsuit against Cipla, alleging that the Indian drugmaker has violated…
Read More »